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PERSPECTIVES ON DRUGS 
The role of psychosocial  
interventions in drug treatment
Psychosocial interventions are structured psychological 
or social interventions used to address substance-related 
problems. They can be used at different stages in the 
treatment journey, to identify the problem, treat it and assist 
with social reintegration. These dynamic interventions may 
also be used alone or in combination at different points in an 
individual’s drug treatment journey. Often, these measures 
are used with clients at their first contact with health services 
to help them to recognise and clarify the nature of their 
drug problem and commit to changing their behaviour. At a 
later stage these interventions are used to support patients 
in treatment; for example, such approaches have become 
central in treating cannabis (EMCDDA, 2015a), cocaine and 
amphetamines use. These interventions are also employed, 
sometimes in conjunction with pharmacological treatment, in 
the treatment of opioid-related problems. They can also help 
clients to maintain behavioural goals and support treatment 
retention. Psychosocial interventions can also involve the 
family and the community during the social reintegration 
phase of drug treatment.
The flexible nature of most psychosocial interventions means 
that treatment providers can use different combinations of 
approaches, taking into consideration the needs of individual 
clients. Service providers may follow different theoretical 
perspectives, which can influence their selection of specific 
interventions. In addition, the same intervention may be used 
at different points in the therapeutic pathway, depending on 
the theoretical assumptions made by different professionals 
about the triggers for an individual’s drug problems (Kleber, 
2013). For example, if a practitioner adheres to automatic 
processing theories, the preferred therapeutic approach will 
focus on changing the individual’s behaviour (EMCDDA, 
2013), and controlling unconscious behaviours will be seen 
as central to making progress in drug treatment. Irrespective 
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of the theoretical basis, psychosocial interventions as a group 
are generally recognised as having value throughout the 
treatment process. In the following sections some of the main 
individual interventions are introduced. 
I  Psychosocial interventions to help people to recognise their drug use problems
Motivational interviewing is a collaborative conversation style 
for strengthening a person’s own motivation and commitment 
to change (Miller and Rollnick, 2013). It is used to help people 
with different types of drug problems. Frequently, individuals 
are not fully aware of their drug problems or they can be 
ambivalent about their problems. Motivational interviewing is 
often referred to as a conversation about change and it is used 
to help assist drug users to identify their need for change. It 
seeks to address an individual’s ambivalence about their drug 
problems, as this is considered the main barrier to change. 
It follows five stages: (1) expressing empathy for the client; 
(2) helping the client to identify discrepancies between their 
behaviour and their goals; (3) avoiding arguments with the 
patients about their motivations and behaviours; (4) rolling 
with the resistance of the patients to talk about some issues; 
and (5) supporting the patients’ sense of self-efficacy.
Motivational interviewing is used to promote change in many 
different situations and settings, including in outpatient 
services and primary care. It is used in prisons (www.nta.
nhs.uk/uploads/phemappingmanual.pdf), by social services 
and in the workplace. Motivational interviewing can be 
provided by therapists, counsellors or other specifically 
trained professionals. It can be used to help someone make a 
decision, to start and follow a pharmacological treatment or 
as a standalone psychological treatment. Generally, however, 
motivational interviewing is undertaken in multiple sessions 
over a period of weeks and at follow-up points during a 
course of treatment. The approach is supported by evidence, 
with a recent systematic review (Smedslund et al., 2011) 
of 59 studies involving 13 342 participants concluding that 
it can reduce the extent of substance abuse compared to 
no intervention. Another systematic review focused on the 
effectiveness of motivational interviewing for drug use among 
adolescents (Barnett et al., 2012) and included 39 studies, 
of which 67 % reported statistically significant improved 
substance use outcomes. 
Brief interventions use the collaborative conversation style 
of motivational interviewing to address problematic or risky 
drug use, but are delivered in a shorter timeframe, ranging 
from 5–30 minutes. Personalised feedback is provided on 
a person’s substance use. This enables them to understand 
their use in relation to other people’s use. In this approach, the 
therapist asks for permission to talk about the possible drug or 
alcohol use and help the client to position him/herself on 
a scale of use. Questions are asked about the benefits and 
harms of substance use in an attempt to elicit a motivation 
to change. In concluding the brief session, a plan for change 
and a follow-up is negotiated. Brief interventions consist of 
five phases, called the ‘5As’ — ask, advise, assess, assist and 
arrange (Babor et al., 2007).
A study in the United States has shown that this approach 
is used in many different settings, including emergency 
departments, primary care and services for the homeless, in 
order to address the problems people have as a result of their 
substance use by getting them to reflect and consider making 
a change (Saitz, 2014). While brief interventions are often 
based on the techniques from motivational interviewing, the 
evidence to support their use is still developing and there is a 
need for further research (Taggart et al., 2013; Yuma-Guerrero 
et al., 2012).
I  Psychosocial interventions for treating drug problems  
Cognitive behavioural therapy (CBT) is an umbrella term that 
encompasses cognitive therapy on its own and in conjunction 
with different behavioural strategies. Cognitive therapy is 
based on the principle that the way individuals perceive and 
process reality influences the way they feel and behave. As 
part of drug treatment, cognitive therapy helps clients to build 
self-confidence and address the thoughts that are believed 
to be at the root of their problems. Clients are helped to 
recognise the triggers for substance use and learn strategies 
to handle those triggers. Treatment providers work to help 
patients to identify alternative thoughts to those that lead to 
their drug use, and thus facilitate their recovery. Generally, 
cognitive therapy is provided after a client has been 
diagnosed as having drug dependence problems. Cognitive 
therapies are delivered by licensed psychotherapists in 
outpatient settings, and sessions can also be available in 
residential treatment facilities and prisons. A meta-analysis 
of studies on the use of cognitive therapies found positive 
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results in terms of the reduction in substance use (Magill and 
Ray, 2009).
Family therapy is used to treat drug use and the problem 
behaviours that can be associated with it. It is particularly 
relevant during adolescence, when substance misuse 
typically causes a group of problems including psychiatric 
symptoms, problems at school and high-risk sexual 
behaviour. Both family therapy and couples therapy are 
supported by a wide theoretical basis (Gurman and Kniskern, 
1991). Family therapy is usually provided when a young 
person’s drug problem, and the means of treating it, are 
considered best addressed using a systemic approach.
Here, the underlying idea is that treating an individual in 
isolation would not solve the problems with the family system 
that are resulting in the drug use. Family therapies can be 
delivered by specialists in outpatient settings, but can also 
be provided in the client’s home (Rigter, 2012). Evidence in 
support of multidimensional family therapy (EMCDDA, 2014)  
and couple-based therapy (McHugh et al., 2010) in reducing 
drug use and related problems is accumulating; and the use 
of family-based interventions (e.g. Strengthening Families) 
for both prevention and treatment of adolescent substance 
misuse is also well evidenced.
I  Psychosocial interventions for helping people to follow treatment and achieve social reintegration
Contingency management refers to a set of interventions 
involving concrete rewards for clients that achieve target 
behaviours. This approach is based around recognising and 
controlling the relationship between behaviours and their 
consequences (Petry et al., 2001). Initially introduced in the 
treatment of alcohol-related problems (Higgins and Petry, 
1999), contingency management can be applied to drug 
users with different types of problems in a variety of settings. 
It has been used, for example, with opioid and cocaine users, 
as well as with homeless clients. Contingency management 
is used to maintain abstinence by reinforcing and rewarding 
alternative behaviours to drug use with the aim of making 
abstinence a more positive experience. Contingency 
management programmes can, for example, be used during 
drug treatment to reward a user remaining abstinent or to 
incentivise a user’s presence at work in a social reintegration 
programme.
A recent systematic review commissioned by the EMCDDA 
concluded that contingency management might be helpful 
in retaining patients in treatment, and that it helps patients 
to abstain from cocaine use during treatment, and helps 
patients to maintain abstinence (EMCDDA, 2015b).
Self-help groups are voluntary not-for-profit organisations 
where people meet to discuss and address shared problems, 
such as alcohol, drug or other addictions. Participants seek 
to provide support for each other, with senior members often 
mentoring or ‘sponsoring’ new ones. Prominent examples 
include Alcoholics Anonymous and Narcotics Anonymous, 
and there is a range of other groups with similar purposes. 
As well as helping drug users, some self-help groups exist 
to support the family members of people with alcohol- and 
drug-related problems. Self-help groups can be used to help 
people to recognise their drug-related problems and can be 
a support during drug treatment, and they can help users to 
maintain abstinence and prevent relapse. The groups aim to 
create a drug-free supportive network around the individual 
during the recovery process and provide opportunities to 
share experiences and feelings. Self-help groups are usually 
led by former drug users (but groups led by professionals 
also exist) or other peers in a range of places within the 
community, and in healthcare and prison settings. For various 
reasons, including privacy concerns, there are few studies 
that assess the evidence for and impact of self-help groups.
Interactive: psychosocial interventions on a drug user‘s treatment journey available 
on the EMCDDA website: www.emcdda.europa.eu/topics/pods/psychosocial-
interventions
I  Interactive element
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I Conclusions
Psychosocial interventions are now well established as 
part of the processes of drug treatment and recovery, and 
ongoing research in support of their use is accumulating. 
They continue to play an important role in treating a range 
of drug problems and addictive behaviours. Psychosocial 
interventions are widely used in the treatment of people 
with cannabis problems, and are key interventions in the 
treatment process for cocaine and methamphetamine users, 
where other measures, such as pharmacotherapies, are 
still under development. In addition, substitution treatment 
often in combination with psychosocial interventions is the 
most common treatment for opioid dependence in Europe. 
The available evidence supports this combined approach for 
keeping patients in treatment, as well as for reducing illicit 
opioid use, drug-related harms and mortality.
Psychosocial interventions can help drug users to identify 
their drug-related problems and make a commitment to 
change, help clients to follow the course of treatment and 
reinforce their achievements. They can also have a role in 
supporting family members and creating a network to help 
facilitate the recovery process. In a broader perspective, they 
are being used at different points in the treatment pathway 
of a wide range of clients, and their role is expanding through 
their use in Internet-based drug treatment modalities.
I  Terms and definitions 
Psychosocial interventions are structured psychological 
or social interventions used to address substance-related 
problems. They can be used at different stages of drug 
treatment to identify the problem, treat it, and assist with 
social reintegration.
Motivational interviewing is a collaborative conversation 
style aimed at strengthening a person’s motivation and 
commitment to change (Miller and Rollnick, 2013). It 
is used in many situations where someone needs to 
be helped to take a decision, and it can be provided 
by therapists, counsellors or other specially trained 
professionals.
Brief interventions use the collaborative conversation 
style of motivational interviewing to address problematic 
or risky drug use, but are delivered in a shorter timeframe, 
ranging from 5–30 minutes. Based on the ‘5As’ — ask, 
advise, assess, assist and arrange — they are delivered 
by professionals including physicians, nurses and other 
healthcare workers (Babor et al., 2007). 
Self-help groups are voluntarily not-for-profit organisations 
where people meet to discuss and address shared 
addiction problems and to provide support for each other, 
with senior members often mentoring or ‘sponsoring’ new 
ones. Self-help groups are usually led by former drug users 
or other peers in a range of places within the community, 
and in healthcare and prison settings.
Cognitive behavioural therapy (CBT) helps clients to 
build self-confidence and address the thoughts that are 
believed to be at the root of their drug problems, and learn 
to recognise and handle what triggers them. Following 
a diagnosis of drug dependence, cognitive therapies 
are delivered by licensed psychotherapists in outpatient 
settings, and sessions can also be available in residential 
treatment facilities and prisons.
Family therapy is used to treat drug use and the problem 
behaviours that can be associated with it, especially 
during adolescence, such as psychiatric symptoms, 
problems at school, delinquency and high-risk sexual 
behaviour. Family therapy can be delivered by specialists 
in outpatient settings, and can also be provided in the 
patient’s home.
Contingency management refers to a set of interventions 
involving concrete rewards for clients that achieve 
target behaviours. It involves rewarding and reinforcing 
behaviours other than drug use and can, for example, 
be used during drug treatment to show that a user is 
remaining abstinent or to incentivise a user’s presence at 
work in a social reintegration programme.
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Contingency management refers to a set of interventions 
involving concrete rewards for clients that achieve target 
behaviours. This approach is based around recognising and 
controlling the relationship between behaviours and their 
consequences (Petry et al., 2001).The EMCDDA has recently 
conducted a systematic review of studies on contingency 
management, which highlighted the diverse application 
of this approach in a range of settings for a variety of drug 
problems (EMCDDA, 2015b). For example, participants 
enrolled in the studies being reviewed had a broad 
spectrum of drug problems, from cannabis use to stimulant 
(amphetamines, cocaine), opioid and polydrug use. 
Contingency management was used alone, as a support for 
other psychosocial interventions or in conjunction with other 
pharmacological treatments. It was also used to reinforce 
different behaviours. These included relapse prevention, 
supporting abstinence, attendance at psychosocial therapy 
groups or to maintain compliance with a pharmacological 
treatment course. Several types of reinforcement 
techniques were used in the studies examined, such 
as monetary incentives, the possibility of taking home 
the substitution treatment medication, or extending the 
period of therapeutic workplace attendance. The review 
identified 38 studies, 34 of which were conducted in the 
United States, three in China and one in Malaysia. Overall, 
the study provided an insight into the many ways in which 
contingency management is currently being used to assist 
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Further reading and relevant websites
I  SBIRT: Screening, Brief Intervention, and Referral to Treatment:  
www.integration.samhsa.gov/clinical-practice/SBIRT
I  What is CBT? www.beckinstitute.org/cognitive-behavioral-therapy/
I  Contingency management for drug users:  
www.emcdda.europa.eu/best-practice/social-reintegration/drug-treatment
I  Cochrane reviews on psychosocial interventions: www.cochranelibrary.com/app/
content/browse/page/?context=editorial-group/Drugs%20and%20Alcohol%20Group
I  William Miller on motivational interviewing (video):  
www.youtube.com/watch?v=cj1BDPBE6Wk
I  A session of family therapy (video): www.youtube.com/watch?v=6JjcIiCJaDo
